microdosing glp-1 for arthritis drugs calm inflammation beyond diabetes and weight loss Microdosing GLP-1s: Reduce Inflammation, Support

Starting Dose and Titration Schedule GLP 1 medications require gradual dose increases

Taking GLP-1s has been shown to reduce markers of inflammation

K., & Gluud, L

Crucially, it's important to understand that sublingual semaglutide is not FDA-approved and is currently only available as a compounded medication

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications with specific UK licences: some are approved for type 2 diabetes management (semaglutide [Ozempic], dulaglutide [Trulicity], liraglutide [Victoza]), while others are specifically licensed for weight management in adults with obesity or overweight with weight-related comorbidities (semaglutide [Wegovy], liraglutide [Saxenda])